Should You Buy Pfizer in April?

It's been 13 months since Pfizer (NYSE: PFE) announced that it was partnering with BioNTech to develop a COVID-19 vaccine. Since then, Pfizer's shares are up more than 26%. That might not seem too bad until you consider that the S&P 500 index has soared nearly 2.5 times as much during the same period.

But in several ways, the future for the big drugmaker looks better than it has in quite a while. Should you buy Pfizer in April? 

Image source: Getty Images.

Continue reading

Source Fool.com